首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Antihyperglycemic and Antihyperlipidemic Effects of Fruit Aqueous Extract of Berberis integerrima Bge. in Streptozotocin-induced Diabetic Rats
【2h】

Antihyperglycemic and Antihyperlipidemic Effects of Fruit Aqueous Extract of Berberis integerrima Bge. in Streptozotocin-induced Diabetic Rats

机译:小Ber果实水提取物的降血糖和降血脂作用。在链脲佐菌素诱导的糖尿病大鼠中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Use of medicinal plants for attenuation of hyperglycemia and restoration of lipids disorder to normal level is clinically very important. The aim of present study was to evaluate the effects of Berberis integerrima Bge. fruit aqueous extract (BIFAE) on blood glucose and lipid profile in streptozotocin (STZ) - induced diabetic rats. The STZ-induced diabetic rats were treated by fruit aqueous extract of Berberis integerrima Bge. at doses (250 and 500 mg/Kg bw) and glibenclamide (0.6 mg/Kg bw) for 42 days by gavage. Blood glucose levels and body weights of rats were measured on weeks 0, 2, 4 and 6. Total lipid levels were determined in normal and STZ-induced diabetic rats after administration of the BIFAE and glibenclamide for 42 days. STZ-induced diabetic rats showed a significant (P<0.001) increases in the levels of blood glucose, triglycerides (TG), total cholesterol (TC), low density lipoprotein LDL-cholesterol (LDL-C) while body weight and high density lipoprotein HDL-cholesterolan (HDL-C) were significantly(P<0.001) decreased compared to normal rats. Daily administration of BIFAE did not possess the hypoglycemic and hypolipidaemic activity in STZ- diabetic rats during 6-week treatment period. Results indicate the usage of BIFAE in traditional medicine for the treatment of diabetes may need more investigation.
机译:在临床上,使用药用植物减轻高血糖和将脂质疾病恢复至正常水平非常重要。本研究的目的是评估小Ber小ber的功效。水果水提取物(BIFAE)对链脲佐菌素(STZ)诱导的糖尿病大鼠血糖和脂质分布的影响。 STZ诱导的糖尿病大鼠用小Ber小fruit果实水提物处理。分别通过强饲法(250和500 mg / Kg bw)和格列苯脲(0.6 mg / Kg bw)服用42天。在给予BIFAE和glibenclamide 42天后,在正常,STZ诱导的糖尿病大鼠中,在第0、2、4和6周测量大鼠的血糖水平和体重。 STZ诱导的糖尿病大鼠血糖,甘油三酸酯(TG),总胆固醇(TC),低密度脂蛋白LDL-胆固醇(LDL-C)的水平显着(P <0.001)增加,而体重和高密度脂蛋白与正常大鼠相比,HDL-胆固醇(HDL-C)显着降低(P <0.001)。在6周的治疗期中,每日服用BIFAE在STZ糖尿病大鼠中不具有降血糖和降血脂活性。结果表明,在传统药物中使用BIFAE治疗糖尿病可能需要更多的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号